Asklepios Klinik Gauting GmbH

Research site

Germany Schuetzenstrasse 55, 23843 Bad Oldesloe, Germany

2 trials recruiting
Heart failure with preserved ejection fraction · Myocardial infarction
Adult patients

About Specializations

Asklepios Klinik Gauting GmbH in Bad Oldesloe, Germany specialises in clinical trials of conditions such as Heart failure with preserved ejection fraction, Myocardial infarction, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Schuetzenstrasse 5523843 Bad OldesloeGermany

Open in maps ↗

Recruiting now: 2 trials
Conditions studied: 2

More sites in Bad Oldesloe Germany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Heart failure with preserved ejection fraction

Recruiting

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:AZD5004
Sponsor:AstraZeneca AB

Contact Research Centre

Myocardial infarction

Recruiting

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

Study on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Research Maatschap Cardiologen Rotterdam Zuid

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites